Efficacy of anakinra in a case of refractory still disease

Journal of Clinical Rheumatology

Volumn 14, Issue 6, 2008, Pages 357-358

  Debiais, Severine ^a   Maillot, Francois ^a   Luca, Luminita ^a   Buret, Jennifer ^a   Fautrel, Bruno ^b   Renard, Jean Paul ^a  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; COLCHICINE; CYCLOSPORIN A; ETANERCEPT; IMMUNOGLOBULIN; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; ANTIRHEUMATIC AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; ADULT ONSET STILL DISEASE; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; HUMAN; LABORATORY TEST; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTIRHEUMATIC AGENTS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; STILL'S DISEASE, ADULT-ONSET; TREATMENT OUTCOME;

EID: 64149090446     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e318188b8d8     Document Type: Article

References (12)

1. Fujii T, Akizuki M, Kameda H, et al. Methotrexate treatment in patients with adult onset Still's disease-retrospective study of 13 Japanese cases. Ann Rheum Dis. 1997;56:144 -148.
2. Efthimiou P, Georgy S. Pathogenesis and management of adult-onset Still's disease. Semin Arthritis Rheum. 2006;363:144-152.
3. Marchesoni A, Ceravolo GP, Battafarano N, et al. Cyclosporin A in the treatment of adult onset Still's disease. J Rheumatol. 1997;24:1582-1587.
4. Vignes S, Wechsler B, Amoura Z, et al. Intravenous immunoglobulin in adult Still's disease refractory to nonsteroidal anti-inflammatory drugs. Clin Exp Rheumatol. 1998;16:295-298.
5. Husni ME, Maier AL, Mease PJ, et al. Etanercept in the treatment of adult patients with Still's disease. Arthritis Rheum. 2002;46:1171-1176.
6. Puertas E, Rondon J, Rondon J. Case report: remission of the adult onset still disease in a young male patient treated with etanercept: 44. J Clin Rheumatol. 2006;12(suppl):S14.
7. Fautrel B, Sibilia J, Mariette X, et al. Tumor necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum. 2005;64:262-266.
8. Vasques Godinho FM, Parreira Santos MJ, Canas Da Silva J. Refractory adult onset Still's disease successfully treated with anakinra. Ann Rheum Dis. 2005;64:647-648.
9. Fitzgerald AA, Leclercq SA, Yan A. Rapid responses to anakinra in patients with refractory adult onset Still's disease. Arthritis Rheum. 2005;52:1794-1803.
10. Rudinskaya A, Trock D. Successful treatment of a patient with refractory adult-onset disease with anakinra. J Clin Rheumatol. 2003;9:330 -332.
11. Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol. 1992;19:424-430.
12. Kwon HJ, Coté TR, Cuffe MS, et al. Case report of heart failure after therapy with tumor necrosis factor antagonist. Ann Intern Med. 2003;10:807- 811.